Announcement PDF 12 January 2024 Company Announcements Office Australian Securities Exchange 20 Bridge Street SYDNEY NSW 2000 Dear Sir/Madam NOTICE UNDER SECTION 708A OF THE CORPORATIONS ACT This notice is given by Race Oncology Limited pursuant to section 708A(5)(e) of the Corporations Act (Act). The Company has today issued 420,000 fully paid ordinary shares (Issued Shares) following the exercise of 420,000 unlisted 21 January 2024 options with an exercise price of $0.12 (Options). Pursuant to section 708A(5)(e) of the Act, the Company gives notice that: 1. the Issued Shares were issued without disclosure to investors under part 6D.2 of the Act; 2. as at the date of this notice, the Company has complied with: (a) the provisions of Chapter 2M of the Act as they apply to the Company; and (b) section 674 and section 674A of the Act; and 3. as at the date of this notice, there is no information that is “excluded information” (as defined in section 708A(7) of the Act) which is required to be disclosed by the Company. Authorised for release by the Board. Peter Webse Company Secretary pwebse@governancecorp.com.au Race Oncology Ltd ABN 61 149 318 749 Registered office: L36, 1 Macquarie Place, Sydney NSW 2000 www.raceoncology.com